Interesting that we have not heard anything on the B-OM results since a month has passed since trial completion. As each day passes, it makes me wonder what the hold up is? Considering that 19 of the 61 patients were already evaluated with the interim results, the remaining 42 patients would have to have been markedly different to impact the results in any direction. Perhaps they are working on an arrangement that they plan to announce with the top line results that is taking some time. Any other ideas?
IMHO only
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links